Estonian biotechnology company Icosagen will start developing a vaccine and a biological therapeutic against the Ebola virus together with the Finnish company FIT Biotech Oy, Eesti Paevaleht Online reports.
Source
Topics
It is forbidden to copy the text of this publication without a written permission from ELTA.